Measuring Analgesic Interventions



Status:Recruiting
Conditions:Chronic Pain
Therapuetic Areas:Musculoskeletal
Healthy:No
Age Range:7 - 21
Updated:1/9/2019
Start Date:October 29, 2018
End Date:June 2020
Contact:Julia C Finkel, MD
Email:jfinkel@childrensnational.org
Phone:2024764867

Use our guide to learn which trials are right for you!

Developing a Method to Objectively Measure Analgesic Interventions: A Pilot Study

It is generally recognized that pain assessment and management especially in newborns,
children and other nonverbal populations is an unmet need. According to the American Medical
Association, "the pediatric population is at risk of inadequate pain management, with
age-related factors affecting pain management in children. Children are often given minimal
or no analgesia for procedures that would routinely be treated aggressively in adults.
Although much is now known about pain management in children, it has not been widely or
effectively translated into routine clinical practice". These two factors combine to
emphasize the necessity for an objective tool to quantify pain and monitor the effectiveness
of analgesia, especially during treatments. Further, it is reported that many patients
require a combination of treatments, and it is often necessary to test a variety of
treatments before the personal match for treatment is found. The method in place to change
the care on a subjective basis is difficult, time consuming, and not easily individualized.
This pilot study is part of an ongoing effort to develop a method to objectively assess
response to specific analgesic interventions. It specifically aims to discern the impact of
analgesic interventions on sensory nerve fiber sensitivity in a diverse patient population.


Inclusion Criteria:

1. The subject is 7 to 21 years of age

2. The subject is receiving an analgesic intervention in the Children's National Medical
Center Pain Clinic

3. The subject is willing and able to provide written informed assent/parental consent to
the study participation.

Exclusion Criteria:

1. Eye pathology precluding pupillometry

2. Patients who are actively using opioids (history of use acceptable). Rationale:
opioids constrict the pupil, and therefore concomitant opioid use would bias our
results.

3. Subjects who are or may be pregnant
We found this trial at
1
site
Washington, District of Columbia 20010
Principal Investigator: Julia C Finkel, MD
?
mi
from
Washington,
Click here to add this to my saved trials